ES2150400A6 - Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
- Google Patents
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbHfiledCriticalSteigerwald Arzneimittelwerk GmbH
Priority to ES009001742ApriorityCriticalpatent/ES2150400A6/en
Publication of ES2150400A6publicationCriticalpatent/ES2150400A6/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract. The patent refers to pharmaceutical composition for treating ulceratic disorders of gastro-intestinal tract. The composition comprises methyl polysiloxanol as active component and solvent or pharmaceutical carrier substance acceptable for oral use.
ES009001742A1990-06-221990-06-22Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
Expired - LifetimeES2150400A6
(en)
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
(-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT.